CTIS.eu › Cities › France › Grenoble Cedex 9
Grenoble Cedex 9
France
563 total trials
252 recruiting
2022-502049-91-00
4
2023-09-26
SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
2024-515264-31-00
3
2025-04-15
PSMA-positive non-curative metastatic castration-resistant prostate ca
2024-511030-12-00
3
2025-02-03
Non-small Cell Lung Cancer (NSCLC)
2023-507680-19-00
4
2024-11-28
Sjögren’s Syndrome
2024-516435-27-00
4
2024-11-05
High-risk myeloïd malignancies
2023-509684-24-00
7
2024-10-31
Hepatitis B
2024-511998-30-00
5
2024-10-18
Narcolepsy with Cataplexy (Narcolepsy Type 1)
2023-509371-16-00
4
2024-09-25
Idiopathic Pulmonary Fibrosis
2023-509573-23-00
4
2024-07-16
Chronic HBV Infection
2023-508445-40-00
4
2024-07-01
Obstructive Sleep Apnea
2023-506696-10-00
5
2024-06-18
Non-Small Cell Lung Cancer
2023-503693-20-01
5
2024-04-10
Severe eosinophilic asthma
2022-501969-42-00
5
2024-03-28
Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criter
2022-502378-17-00
4
2024-03-20
Pulmonary Arterial Hypertension
2023-504678-39-00
4
2024-03-13
Heart Failure
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
2023-505910-10-00
4
2024-01-23
Relapsed or Refractory High-Risk Myelodysplastic Syndrome
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
2023-505108-52-00
5
2023-12-20
Intensive Care
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
2022-502440-12-00
9
2023-11-16
metastatic clear cell renal cancer with progressive disease after 2 li
2022-502476-23-00
4
2023-10-25
Treatment of immunotherapy-naive patients with previously untreated or
2022-501884-41-00
5
2023-09-29
Contrast enhancement in magnetic resonance imaging for assessment of c
2022-501263-41-00
4
2023-08-10
Ulcerative Colitis
Showing 457–480 of 563 trials